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The characterization, in human pancreatic juice, of a binary complex associating procarboxypeptidase A with a 32 kDa 
inactive glycoprotein (G32) is reported in this paper. Free G32 was isolated after dissociation of the binary complex. 
N-terminal sequence analysis revealed acomplete homology between this protein and human protease E (HPE I), except 
for the two strongly hydrophobic N-terminal residues (Val-Val) which are missing in G32. This protein might be a trun- 
cated protease E highly analogous to the subunit III of the ruminant procarboxypeptidase A-S6 ternary complex. The 
analogy with bovine subunit III is further supported by interspecies reassociation experiments showing that bovine pro- 
carboxypeptidase A can specifically bind human G32. 
Protease E; Subunit III; Binary complex; Procarboxypeptidase A; Truncated protease; (Human) 
1. INTRODUCTION 
Pancreatic procarboxypeptidase A presents the 
interesting property of forming complexes with 
other pancreatic proteins. In ruminant species, for 
example, it is mainly secreted as a ternary complex 
(proCPAS6) [l-3] in association with a chymo- 
trypsinogen of the C-type [4,5] and subunit III 
[6,7], an inactive truncated protease E [8]. In por- 
cine pancreas, proCPA is found under two forms, 
monomeric [9- 1 l] and associated with zymogen E 
[12,13]. 
Recently, Pascual et al. [14] have reported, 
besides several monomeric forms of proCPA, the 
presence in human pancreas of a proCPA-zymo- 
gen E binary complex. Interestingly, Guy-Crotte et 
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al. [ 151 identified in the human pancreatic secre- 
tion a glycoprotein of 35 kDa (P35) with a trun- 
cated protease E, highly analogous to bovine 
subunit III. However, it has not been shown 
whether this protein is secreted free or associated 
with proCPA, as in bovine pancreas. 
In this paper, we report the characterization of 
a proCPA-32 kDa protein (G32) binary complex in 
human pancreatic juice and the identification of 
this 32 kDa protein with a truncated protease E 
highly analogous to bovine subunit III. The 
analogy of G32 to human P35 is also discussed. 
2. MATERIALS AND METHODS 
2.1. Materials 
Lyophilized human pancreatic juice devoid of any proteolytic 
activity was a generous gift from Dr Lombardo, Marseilles. 
Ultrogel AcA 54, DE trisacryl and CM Sepharose were pur- 
chased from IBF (Villeneuve la Garenne, France). 
2,3-Dimethylmaleic anhydride, hippuryl-L-phenyllactic acid, 
N-acetyl-L-tyrosine ethyl ester, N-acetyl-L-trialanine methyl 
ester, N-t-Boc-L-alanine p-nitrophenyl ester, phenylmethyl- 
sulfonyl fluoride and Mes were from Sigma (St. Louis, MO, 
USA). Benzamidine was from Fluka (Zurich, Switzerland). 
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2.2. Methods 
2.2.1. Filtration of lyophilized human pancreatic juice on 
AcA 54 Ultrogel 
4.8 g of lyophilized pancreatic juice, collected from a single 
individual, were dissolved in 25 ml of 50 mM Tris-HCl buffer, 
pH 8.0, containing 0.4 M NaCl and 2 mM benzamidine, loaded 
on an AcA 54 Ultrogel column (3 cm x 4 m) and eluted with 
the same buffer. 
2.2.2. Activities measurements 
After tryptic activation, the carboxypeptidase A activity was 
measured as previously described [16] using a 1 mM hippuryl- 
L-phenyllactic acid as substrate. The protease E activity was 
determined either potentiometrically at pH 7.5 and 25°C using 
a 10 mM N-acetyl-trialanine methyl ester solution as substrate 
in a 1 mM Tris-HCl buffer containing 0.1 M NaCl or spec- 
trophotometrically at pH 6.0 and 25°C using as substrate N-t- 
Boc-alanine p-nitrophenyl ester as previously described [17]. 
2.2.3. Zn” content determination 
An aliquot (500~1) of each fraction obtained during pan- 
creatic juice Ultrogel filtration was directly analyzed by flame 
atomic absorption spectrophotometry using a spectrophoto- 
meter Varian model 1275. Measurements were performed at 
213.8 nm (slit 0.5). 
2.2.4. Purification of the proCPAG32 binary complex 
The fractions containing the proCPAG32 binary complex 
eluted from the above-mentioned gel filtration column were 
pooled as indicated in fig.1 (pool l), dialyzed against 25 mM 
Tris-HCl, pH 8.0, containing 25 mM NaCl and 1 mM ben- 
zamidine and chromatographed on a DE trisacryl column (2 cm 
x 15 cm) in the same buffer. Elution was performed with a 
linear NaCl gradient (25-150 mM). 
2.2.5. Dissociation of the proCPAG32 binary complex 
The dissociation of the binary complex (20 mg) was perform- 
ed at pH 6.0 using a two steps procedure: chromatography on 
CM Sepharose followed by AcA 54 Ultrogel filtration. The CM 
Sepharose column (2 cm x 13 cm) was equilibrated in a 10 mM 
Mes buffer, pH 6.0, 50 mM NaCl and 2 mM benzamidine. The 
proteins were eluted by a linear NaCl gradient (50-250 mM) in 
the same buffer (total volume of the gradient, 300 ml). The 
eluted asymmetric peak (not shown) was concentrated in an 
Amicon cell equipped with a PM 10 membrane and loaded on 
an AcA 54 Ultrogel column (1 cm x 2 m) equilibrated in a 
10 mM Mes buffer, pH 6.0, containing 0.2 M NaCl and 2 mM 
benzamidine. The elution was achieved using the same buffer. 
Protein concentrations were estimated assuming a mean value 
of 1.8 for E’% at 280 nm. 
2.2.6. Gel electrophoresis 
Electrophoresis in the presence of SDS was carried out in 
lO-15% polyacrylamide gels as described by Laemmli [18] us- 
ing a PHAST gel apparatus (Pharmacia). 
2.2.7. N-terminal sequence analysis 
N-terminal sequence analysis was performed by a stepwise 
Edman degradation using a gas-phase sequencer (Applied 
Biosystems, model 470 A). The resulting phenylthiohydantoins 
were analyzed by HPLC using a C 18 column (Brownlee 5 pm, 
2.1 x 220 mm). They were eluted by a methanol gradient 
(lO-46%) in a 7 mM sodium acetate buffer @H 4.84). 
2.2.8. Carbohydrate content of G32 
Neutral sugar content was estimated using the phenol sulfuric 
acid method of Dubois et al. [19]. 
2.2.9. Reassociation experiments 
Bovine proCPA (0.17 mg) was mixed at pH 7.2 (25 mM Tris- 
HCl buffer containing 50 mM NaCI) with a slight molar excess 
of human G32. The resulting mixture was then filtered through 
a Superose 12 analytical column using a FPLC apparatus (Phar- 
macia). The elution was performed using the same buffer. 
3. RESULTS AND DISCUSSION 
3.1. Identification of free and associated forms of 
proCPA in human pancreatic juice 
The elution pattern resulting from gel filtration 
of lyophilized human pancreatic juice is shown in 
fig.1. 
Different molecular forms of proCPA were 
detected by activity measurements and Zn*+ con- 
tent analysis (about 1 mol Zn*+/mol protein). SDS 
gel electrophoresis revealed that proCPA occurred 
in human pancreas both as binary complexes, in 
association with a 32 kDa (G32) (pool 1) or 28 kDa 
(pool 2) protein and as a monomer (pool 3). The 
different forms of proCPA were eluted as expected 
from their M, values. No chymotrypsin or protease 
E activity was detected under the two complexes 
even after tryptic incubation. No investigation was 
performed on procarboxypeptidase B. 
SDS gel analysis of the purified binary complex 
proCPA-G32 is presented in fig.2. 
3.2. Dissociation of the proCPA-G32 binary 
complex 
Dissociation of the binary complex was achieved 
at pH 6.0. CM Sepharose chromatography at pH 
6.0 alone failed to completely separate proCPA 
from G32 probably because of their similar p1 
values (5.2-5.4). A complete separation was per- 
formed by gel filtration on AcA 54 Ultrogel at pH 
6.0. This finding leads to the conclusion that the 
two partners are mainly bound through ion pair- 
ing, as observed for the bovine proCPA-subunit 
III interactions. As a matter of fact, the dissoca- 
tion of the complex can also be achieved using 
2,3_dimethylmaleic anhydride as for the bovine 
proCPA-S6 complex [20]. The binary complex 
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Fig.1. Filtration of lyophilized pancreatic juice on AcA 54 Ultrogel (see section 2). Volume fraction, 3.2 ml. Flow rate, 32 ml/h. The 
peaks in which a potential carboxypeptidase A activity was detected are indicated by arrows. CEH, carboxylic ester hydrolase. 
Fig.2. SDS gel electrophoresis of the purified binary complex 
proCPA-G32. Lanes: a, purified binary complex; b, molecular 
mass markers. 
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proCPA-28 kDa protein was also dissociated using 
the latter method. 
3.3. Characterization of G32 
Isolated G32 appears to be devoid of any 
chymotryptic or elastolytic activity since it failed to 
hydrolyze N-acetyl tyrosine ethyl ester, trialanine 
methyl ester and t-Boc-alanine p-nitrophenyl ester 
even after trypsic incubation. 
The N-terminal sequence of G32 is reported in 
table 1 and compared to the sequences of human 
P 35 [15], protease E isoenzymes (HPEl , HPE2) 
[21,22] and to bovine subunit III [23]. Human 
G32, like bovine subunit III and human P 35, lacks 
the N-terminal dipeptide Val-Val. Apart from this 
difference, a complete identity can be observed 
between the N-terminal sequences of HPEl and 
this protein. Interestingly, reassociation ex- 
periments clearly demonstrated that human G32 
was able to bind to monomeric bovine proCPA 
(data not shown). This finding emphasizes the 
homology between human G32 and bovine subunit 
III. It must be pointed out that carbohydrates are 
not likely to be involved in the interaction 
proCPA-G32, since bovine subunit III is not 
glycosylated. 
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Table I 
N-terminal sequences of human 32 kDa protein (G32), P 35 [15], HPE 1 
[21,22], HPE 2 [21] and bovine subunit III [23] 
1 5 10 15 20 
HPE 1 VVNGEDAVPYSWPWQVSLQYEK 
HPE 2 VVEGEDAVPYSWPWQVSLQYEK 
Human G32 --NGEDAVPYSWPWQVSLQYEK 
Human P 35 --XGEDAVPYSWPWQVSLQYEK 
Bovine subunit III --NGEDAVPYS WS_WQVSLQYEK 
(- ) Missing residue; (X) unknown residue. The residues different from the 
G32 protein sequence have been underlined 
Since the N-terminal residue of human P 35 has 
not been determined, the identity of.G32 with P 35 
cannot be definitely ascertained. However, car- 
bohydrate analysis further supported an identity 
between both proteins. G32 was shown to contain 
6.8% carbohydrates which is in good agreement 
with the results obtained by Guy-Crotte et al. [15] 
for human P 35. 
4. CONCLUSION 
We have shown that human pancreatic proCPA 
is secreted, for one part, in association with a 
glycosylated 32 kDa protein (G32). This protein is 
likely to be identical with the human P 35 de- 
scribed by Guy-Crotte et al. [15] and could be iden- 
tified as an inactive truncated protease E. Besides 
this binary complex, another complex in which 
proCPA is associated with a 28 kDa protein has 
been found. This protein, which has not yet been 
identified, might be either a different protein or a 
degraded product. 
The occurrence of a truncated protease E 
associated with proCPA was first described in 
bovine pancreas [8]. The finding of such an 
association in other species (man) added to in- 
terspecies conservation of the proCPA-truncated 
protease E binding site raises the question of the 
physiological significance of the association. 
Preliminary studies performed on the bovine 
proCPA-S6 complex have shown that such an 
association results in a stabilization and an im- 
provement of the catalytic efficiency of proCPA 
]7,161. 
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